Product nameAnti-TROVE2/SS-A antibody
See all TROVE2/SS-A primary antibodies
DescriptionRabbit polyclonal to TROVE2/SS-A
Tested applicationsSuitable for: ICC/IF, WBmore details
Species reactivityReacts with: Human
Predicted to work with: Mouse
- WB: RT-4 and U-251 MG cell lysate; human liver and tonsil tissue lysate. ICC/IF: U-251 MG cells.
Protein previously labeled as TROVE2.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
Storage bufferpH: 7.20
Preservative: 0.02% Sodium azide
Constituents: 40% Glycerol, PBS
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab219973 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ICC/IF||Use a concentration of 1 - 4 µg/ml.
Fixation/Permeabilization: PFA/Triton X-100
|WB||1/100 - 1/250. Predicted molecular weight: 61 kDa.|
FunctionRNA-binding protein that binds to several small cytoplasmic RNA molecules known as Y RNAs. May stabilize these RNAs from degradation.
Sequence similaritiesBelongs to the Ro 60 kDa family.
Contains 1 TROVE domain.
modificationsPhosphorylated upon DNA damage, probably by ATM or ATR.
Cellular localizationCytoplasm. Localized in cytoplasmic mRNP granules containing untranslated mRNAs.
- Information by UniProt
- 60 kDa ribonucleoprotein Ro antibody
- 60 kDa Ro protein antibody
- 60 kDa SS A/Ro ribonucleoprotein antibody
All lanes : Anti-TROVE2/SS-A antibody (ab219973) at 1/100 dilution
Lane 1 : RT-4 cell line lysate
Lane 2 : U-251 MG cell line lysate
Lane 3 : Human plasma lysate
Lane 4 : Human liver tissue lysate
Lane 5 : Human tonsil tissue lysate
Predicted band size: 61 kDa
Immunofluorescent analysis of paraformaldehyde-fixed, Triton X-100 permeabilized U-251 MG cells labeling TROVE2/SS-A with ab219973 at 4 μg/mL dilution (green).
ab219973 has not yet been referenced specifically in any publications.